je.st
news
Arca Biopharma Rating Reiterated by RBC Capital
2015-10-18 18:09:25| Biotech - Topix.net
's stock had its "sector perform" rating restated by stock analysts at RBC Capital in a research note issued to investors on Sunday, MarketBeat.com reports. They presently have a $7.00 price target on the biopharmaceutical company's stock, down from their prior price target of $8.00.
Tags: rating
capital
rbc
arca
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||